http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4331804-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-224 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-224 |
filingDate | 1979-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1982-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c301d2c74f2fd0ecbebe0956d5c5c2fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_103e1b69351808de7a905e7aa1194639 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1053db25f7eb47b08e925a4628ce08b3 |
publicationDate | 1982-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4331804-A |
titleOfInvention | 2-Epi-fortimicin A and derivatives |
abstract | What is described is 2-epi-fortimicin A, 2-epi-fortimicin B or a 2-epi-fortimicin B derivative represented by the formula: <IMAGE> wherein R1 is hydrogen or loweralkyl; R2 is hydrogen or hydroxy; R3 is methyl or hydrogen; and R4 is selected from the group consisting of hydrogen, loweralkyl, aminoloweralkyl, diaminoloweralkyl, N-loweralkylaminoalkyl, N,N-diloweralkylaminoloweralkyl, hydroxyloweralkyl, aminohydroxyloweralkyl, N-loweralkylaminohydroxyloweralkyl, N,N-diloweralkylaminohydroxyloweralkyl, acyl of the formula <IMAGE> wherein R5 is loweralkyl, aminoacyl, diaminoacyl, hydroxyacyl, N-loweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl or an amino acid residue other than those defined above and the pharmaceutically acceptable salts thereof useful in the treatment of infections. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4418193-A |
priorityDate | 1979-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 226.